SKINHEALTH SYSTEMS INCSKIN
ASignal's systematic analysis rates SKIN as Neutral.
Reflects the latest available analysis · analyzed Oct 25, 2026
The case on SKIN
Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.
- Positive MACD histogram indicating strengthening upward momentum
- Price above 20-day and 50-day moving averages suggesting uptrend
- High gross margin of 66.35% indicating pricing power
- Free cash flow positive at $27.48M
- Low forward P/E of 2.85x suggesting potential undervaluation
- Negative profit margin (-9.80%) and return on equity (-43.89%)
- High debt-to-equity ratio of 6.61x indicating financial risk
- Declining revenue growth (YoY: -7.80%)
- Only one news source available, limiting sentiment reliability
- No Reddit mentions, indicating low retail investor interest
See the full verdict on SKIN
ASignal Rank (1-4), confidence score, Buffett / Ackman / Dalio grades, price targets, and the full reasoning behind the call.
How ASignal analyzes SKIN
Most investors never get a second opinion, let alone several. ASignal runs SKIN past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: Warren Buffett's value discipline, Bill Ackman's activist lens, and Ray Dalio's macro view. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.
The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.